These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10633308)

  • 41. Juvenile Huntington's Disease: Diagnostic and Treatment Considerations for the Psychiatrist.
    Quigley J
    Curr Psychiatry Rep; 2017 Feb; 19(2):9. PubMed ID: 28168595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease.
    Georgiou N; Bradshaw JL; Chiu E; Tudor A; O'Gorman L; Phillips JG
    Mov Disord; 1999 Mar; 14(2):320-5. PubMed ID: 10091627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Huntington's disease.
    Kent A
    Nurs Stand; 2004 Apr 21-27; 18(32):45-51; quiz 52-3. PubMed ID: 15132037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
    Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
    J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.
    Alpay M; Koroshetz WJ
    Psychosomatics; 2006; 47(1):70-2. PubMed ID: 16384811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dissociating emotional and cognitive empathy in pre-clinical and clinical Huntington's disease.
    Maurage P; Lahaye M; Grynberg D; Jeanjean A; Guettat L; Verellen-Dumoulin C; Halkin S; Heeren A; Billieux J; Constant E
    Psychiatry Res; 2016 Mar; 237():103-8. PubMed ID: 26869362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?
    Killoran A; Biglan KM
    Mov Disord; 2014 Sep; 29(11):1404-13. PubMed ID: 25164707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychiatry of Huntington's disease and other basal ganglia disorders.
    Rosenblatt A; Leroi I
    Psychosomatics; 2000; 41(1):24-30. PubMed ID: 10665265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluoxetine in the treatment of Huntington's disease.
    De Marchi N; Daniele F; Ragone MA
    Psychopharmacology (Berl); 2001 Jan; 153(2):264-6. PubMed ID: 11205429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychogenic non-epileptic seizures in early Huntington's disease.
    Rodrigues FB; Wild EJ
    Pract Neurol; 2016 Dec; 16(6):452-454. PubMed ID: 27330140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The current clinical management of Huntington's disease.
    Phillips W; Shannon KM; Barker RA
    Mov Disord; 2008 Aug; 23(11):1491-504. PubMed ID: 18581443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dysphagia in Huntington's disease.
    Hunt VP; Walker FO
    J Neurosci Nurs; 1989 Apr; 21(2):92-5. PubMed ID: 2523455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural history of Huntington disease.
    Dorsey ER; Beck CA; Darwin K; Nichols P; Brocht AF; Biglan KM; Shoulson I;
    JAMA Neurol; 2013 Dec; 70(12):1520-30. PubMed ID: 24126537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in cognitive control in pre-manifest Huntington's disease examined using pre-saccadic EEG potentials - a longitudinal study.
    Ness V; Bestgen AK; Saft C; Beste C
    J Huntingtons Dis; 2014; 3(1):33-43. PubMed ID: 25062763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.
    Epping EA; Kim JI; Craufurd D; Brashers-Krug TM; Anderson KE; McCusker E; Luther J; Long JD; Paulsen JS;
    Am J Psychiatry; 2016 Feb; 173(2):184-92. PubMed ID: 26472629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subjective sleep problems in Huntington's disease: A pilot investigation of the relationship to brain structure, neurocognitive, and neuropsychiatric function.
    Baker CR; Domínguez D JF; Stout JC; Gabery S; Churchyard A; Chua P; Egan GF; Petersén Å; Georgiou-Karistianis N; Poudel GR
    J Neurol Sci; 2016 May; 364():148-53. PubMed ID: 27084236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychiatric features of Huntington's disease: recent approaches and findings.
    Folstein SE; Folstein MF
    Psychiatr Dev; 1983; 1(2):193-205. PubMed ID: 6232607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The potential of composite cognitive scores for tracking progression in Huntington's disease.
    Jones R; Stout JC; Labuschagne I; Say M; Justo D; Coleman A; Dumas EM; Hart E; Owen G; Durr A; Leavitt BR; Roos R; O'Regan A; Langbehn D; Tabrizi SJ; Frost C
    J Huntingtons Dis; 2014; 3(2):197-207. PubMed ID: 25062862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.